Macrocephaly and sclerosis of the tubular bones in an isolated patient: A mild case of craniodiaphyseal dysplasia?

Clinical Dysmorphology

Volumn 12, Issue 4, 2003, Pages 245-250

  Janssens, Katrien ^a   Thompson, Elizabeth ^b   Vanhoenacker, Filip ^c   Savarirayan, Ravi ^d   Morris, Lloyd ^b   Dobbie, Angus ^e   Van Hul, Wim ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e University of Antwerp T6 ^*

Author keywords

Camurati Engelmann disease; Craniodiaphyseal dysplasia; Craniofacial hyperostosis; Endosteal hyperostosis (Worth type); High bone mass trait; Sclerosteosis; Van Buchern disease

Indexed keywords

ADULT; ARTICLE; BONE DYSPLASIA; BONE MASS; CAMURATI ENGELMANN SYNDROME; CASE REPORT; CRANIODIAPHYSEAL DYSPLASIA; DIFFERENTIAL DIAGNOSIS; ENDOSTEAL HYPEROSTOSIS; FEMALE; GENE MUTATION; HUMAN; HYPEROSTOSIS; LEG PAIN; MACROCEPHALY; MUTATIONAL ANALYSIS; OSTEOSCLEROSIS; PRIORITY JOURNAL; VAN BUCHEM DISEASE;

BONE MORPHOGENETIC PROTEINS; CAMURATI-ENGELMANN SYNDROME; CRANIOFACIAL ABNORMALITIES; FEMALE; GENETIC MARKERS; HUMANS; HYPEROSTOSIS; LDL-RECEPTOR RELATED PROTEINS; MIDDLE AGED; RECEPTORS, LDL; SEVERITY OF ILLNESS INDEX; SKULL; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0142107417     PISSN: 09628827     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019605-200310000-00007     Document Type: Article

References (27)

1. Balemans W, Ebeling M, Patel N, Van Hul E, Oison P, Dioszegi M, et al. (2001). Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:537-543.
2. Balemans W, Patel N, Ebeling M, Van Hul E, Wuyts W, Lacza C, et al. (2002). Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet 39:91-97.
3. Bonucci E, Menichini G, Scarfo GB, Tomaccini D (1977). Histologic, microradio-graphic and electron microscopic investigations of bone tissue in a case of craniodiaphyseal dysplasia. Virchows Arch Pathol Anat Histol 373:167-175.
4. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, et al. (2002). High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 16:1515-1521.
5. Brueton LA, Winter RM (1990). Cardiodiaphyseal dysplasia. J Med Genet 27:701-706.
6. Chohayeb AA, Volpe AR (2001). Occurrence of torus palatinus and mandibularis among women of different ethnic groups. Am J Dent 15:278-280.
7. Gorlin RJ, Cohen MM (1969). Frontometaphyseal dysplasia. A new syndrome. Am J Dis Child 118:487-494.
8. Gorlin RJ, Winter RB (1980). Frontometaphyseal dysplasia - evidence for X-linked inheritance. Am J Med Genet 5:81-84.
9. Hall CM (2002). International nosology and classification of disorders of bone (2001). Am J Med Genet 113:65-77.
10. Hall CM, Shaw DG (1994). Computer diagnosis of skeletal dysplasias and malformation syndromes. Acta Paediatr Suppl 406:73-76.
11. Halliday J (1949). A rare case of bone dystrophy. Br J Surg 37:52-63.
12. International Working Group on Constitutional Diseases of Bone (1998). International nomenclature and classification of the osteochondrodysplasias (1997). Am J Med Genet 79:376-382.
13. Joseph R, Lefebvre J, Guy E, Job JC (1958). Dysplasia cranio-diaphysaire progressive. Ann Radial 1:477-490.
14. Janssens K, Gershoni B, Guañabens N, Migone N, Ralston S, Bonduelle M, et al. (2000). Mutations in the gene encoding the latency-associated peptide of TGF-beta1 cause Camurati-Engelmann disease. Nat Genet 26:273-275.
15. Kozlowski K, Beighton P (2001). Skeletal dysplasia syndromes. In: Kozlowski K, Beighton P (editors): Gamut index of skeletal dysplasias. Berlin: Springer; p. 113.
16. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C et al. (2002). A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet 70:11-19.
17. McKeating JB, Kershaw CR (1987). Craniodiaphyseal dysplasia. Partial suppression of osteoblastic activity in the severe progressive form with calcitonin therapy. J R Nav Med Serv 73:81-93.
18. McPherson RI (1974). Craniodiaphyseal dysplasia, a disease or group of diseases? J Can Assoc Radiol 25:22-33.
19. Naique S, Laheri VJ (2001). Stenosis of the cervical canal in Craniodiaphyseal dysplasia. J Bone Joint Surg Br 83:328-331.
20. Penchaszadeh VB, Gutierriz ER, Figeueroa EP (1980). Autosomal recessive craniometaphyseal dysplasia. Am J Med Genet 5:43-55.
21. Richards A, Brain C, Dillon MJ, Bailey CM (1996). Craniometaphyseal and craniodiaphyseal dysplasia, head and neck manifestations and management. J Laryngol Otol 110:328-338.
22. Schaefer B, Stein S, Oshman D, Rennert O, Thurnau G, Wall J, et al. (1986). Dominantly inherited craniodiaphyseal dysplasia: a new craniotubular dysplasia. Clin Genet 30:381-391.
23. Stransky E, Mabilangan I, Tara RT (1962). On Paget's disease with leontiasis ossea and hyperthreosis starting in early childhood. Ann Paediatr 199: 393-408.
24. Superti-Furga A, Bonafé L, Rimoïn DL (2001). Molecular-pathogenic classifica-tion of genetic disorders of the skeleton. Am J Med Genet 106:282-293.
25. Tucker AS, Klein L, Antony GJ (1976). Craniodiaphyseal dysplasia: evolution over a five-year period. Skeletal Radiol 1:47-53.
26. Vanhoenacker FM, De Beuckeleer LH, Van Hul W., Balemans W, Tan GJ, Hill SC et al. (2000). Sclerosing bone dysplasias: genetic and radioclinical features. Eur Radiol 10:1423-1433.
27. Van Wesenbeeck L, Cleiren E, Gram J, Beals RK, Benichou O, Scopelliti D et al. (2003). Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet 72:763-771.